Page 10 - Vik Bebarta News Today

J. Alexander Kueng, Thomas Lane and Tou Thao, the other three former officers on the scene with Derek Chauvin, are on trial for a federal civil rights charge of failing to provide aid to George Floyd while he was in their custody.

ST. PAUL, Minn. (AP) — A toxicologist testified Wednesday at the federal trial of three...

A toxicologist who testified at the ongoing federal trial for three former Minneapolis police officers accused of violating George Floyd’s civil rights said Wednesday that neither drug use, nor heart disease, nor "excited delirium" caused Floyd’s May 2020 death.

J. Alexander Kueng, Thomas Lane and Tou Thao, the other three former officers on the scene with Derek Chauvin, are on trial for a federal civil rights charge of failing to provide aid to George Floyd while he was in their custody.

A toxicologist testified Wednesday at the federal trial of three former officers charged with violating George Floyds civil rights that it wasnt drug use, heart disease nor an agitated state known as “excited delirium” that caused Floyds death after officers pinned him to the pavement in May 2020.

J. Alexander Kueng, Thomas Lane and Tou Thao, the other three former officers on the scene with Derek Chauvin, are on trial for a federal civil rights charge of failing to provide aid to George Floyd while he was in their custody.

J. Alexander Kueng, Thomas Lane and Tou Thao, the other three former officers on the scene with Derek Chauvin, are on trial for a federal civil rights charge of failing to provide aid to George Floyd while he was in their custody.

News Category Global Banking & Finance Reviews Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection December 22, 2020 Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receiv...

December 22, 2020 Cambridge, MA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-clear...